Oncolytics Biotech Inc. (ONC.TO)

CAD 1.1

(-2.65%)

Annual Balance Sheets

(In CAD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 38.82 Million 37.33 Million 45.88 Million 34.34 Million 19.65 Million 14.86 Million
Total Current Assets 38.17 Million 35.68 Million 44.9 Million 33.73 Million 18.93 Million 14.45 Million
Cash And Short Term Investments 34.91 Million 32.13 Million 41.26 Million 31.21 Million 14.14 Million 13.69 Million
Cash and Cash Equivalents 31.53 Million 11.66 Million 41.26 Million 31.21 Million 14.14 Million 13.69 Million
Short Term Investments 3.37 Million 20.47 Million 1.36 Million 30.36 Million 13.05 Million -
Net Receivables 15 Thousand 521 Thousand 866.05 Thousand 89.66 Thousand 2.06 Million 51.65 Thousand
Inventory - - - - - -
Other Current Assets 3.24 Million 3.02 Million 2.77 Million 2.42 Million 2.71 Million 700.98 Thousand
Total Non-Current Assets 646.99 Thousand 1.65 Million 976.29 Thousand 609.13 Thousand 727.48 Thousand 412.73 Thousand
Net PPE 647 Thousand 652 Thousand 976.29 Thousand 609.13 Thousand 727.48 Thousand 412.73 Thousand
Good Will And Intangible Assets - - - - - -
Good Will - - - - - -
Intangible Assets - - - - - -
Long-Term Investments - - - - - -
Tax Assets - - - - - -
Other Non Current Assets -1.00 998 Thousand - - - -
Other Assets 1.00 -0.00 - - - -
Total Liabilities 11.25 Million 10.83 Million 9.78 Million 9.59 Million 19.76 Million 8.66 Million
Total Current Liabilities 4.23 Million 3.94 Million 2.68 Million 2.7 Million 12.86 Million 2.81 Million
Account Payables 1.08 Million 2.25 Million 594 Thousand 1805.02 3173.22 1.82 Million
Tax Payables - - - - - -
Short Term Debt 133 Thousand 216 Thousand 293.67 Thousand 248.88 Thousand 339.84 Thousand -
Deferred Revenue -1.08 Million - -594 Thousand -1805.02 -3173.22 927.4 Thousand
Other Current Liabilities 4.1 Million 1.47 Million 2.39 Million 2.46 Million 12.52 Million 61.32 Thousand
Total Non Current Liabilities 7.02 Million 6.88 Million 7.09 Million 6.88 Million 6.89 Million 5.85 Million
Long-Term Debt 290 Thousand 157 Thousand 361.08 Thousand 153.17 Thousand 166.42 Thousand -
Deferred Revenue Non Current 6.73 Million 6.73 Million 6.73 Million 6.73 Million 6.73 Million 5.8 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 290 Thousand 6730.00 6730.00 6730.29 6730.29 52.42 Thousand
Other Liabilities - - - - - -
Total Equity 27.56 Million 26.5 Million 36.09 Million 24.75 Million -107.89 Thousand 6.19 Million
Stock Holders Equity 27.56 Million 26.5 Million 36.09 Million 24.75 Million -107.89 Thousand 6.19 Million
Common Stock 430.9 Million 404.04 Million 391.34 Million 356.82 Million 311.07 Million 285.19 Million
Retained Earnings -446 Million -418.25 Million -393.41 Million -367.11 Million -344.6 Million -311.48 Million
Accumulated other comprehensive income 544 Thousand 662 Thousand 387.73 Thousand 400.22 Thousand 464.1 Thousand 607.5 Thousand
Common Stock Equity 27.56 Million 26.5 Million 36.09 Million 24.75 Million -107.89 Thousand 6.19 Million
Capital Lease Obligation 290 Thousand 373 Thousand 654.75 Thousand 402.05 Thousand 506.27 Thousand -
Total Investments 3.37 Million 20.47 Million 1.36 Million 30.36 Million 13.05 Million -
Total Debt 423 Thousand 373 Thousand 654.75 Thousand 402.05 Thousand 506.27 Thousand -
Net Debt -31.11 Million -11.29 Million -40.6 Million -30.81 Million -13.64 Million -13.69 Million

Balance Sheet Charts